Osiris Therapeutics (OSIR)

Add to Watchlists Create an Alert
11.02 -0.05  -0.45%   NASDAQ May 24, 5:01PM BATS Real time Currency in USD

Osiris Therapeutics SG&A Expense Quarterly:

2.889M for Dec. 31, 2012
View Full Chart

Osiris Therapeutics SG&A Expense Quarterly Chart

    Osiris Therapeutics Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 2.889M
    Dec. 31, 2012 1.755M
    Sept. 30, 2012 1.60M
    June 30, 2012 1.418M
    March 31, 2012 1.523M
    Dec. 31, 2011 1.476M
    Sept. 30, 2011 1.429M
    June 30, 2011 3.28M
    March 31, 2011 1.696M
    Dec. 31, 2010 1.773M
    Sept. 30, 2010 1.268M
    June 30, 2010 1.602M
    March 31, 2010 1.807M
    Dec. 31, 2009 2.062M
    Sept. 30, 2009 1.511M
       
    June 30, 2009 2.321M
    March 31, 2009 2.913M
    Dec. 31, 2008 2.309M
    Sept. 30, 2008 1.887M
    June 30, 2008 1.782M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    OSIR SG&A Expense Quarterly Benchmarks

    Companies
    Cytokinetics 3.634M
    Athersys 0.071M
    Cleveland BioLabs 2.142M

    OSIR SG&A Expense Quarterly Rankings

    Overall 50th percentile
    3955 of 8009
    Sector 41st percentile
    405 of 687 in Healthcare
    Industry 53rd percentile
    115 of 248 in Biotechnology

    OSIR SG&A Expense Quarterly Range, Past 5 Years

    Minimum 1.268M Sep 2010
    Maximum 3.280M Jun 2011
    Average 1.915M